Claris Advisors’s Astrana Health ASTH Stock Holding History

Claris Advisors’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2	Closed	-$116	–	1211
2024 Q3	$116	Buy	+2	New	+$98	﹤0.01%	1111

Other funds holding ASTH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Claris Advisors's ASTH Position: Q4 2024 in Review

Claris Advisors sold out of Astrana Health (ASTH) in Q4 2024, closing a stake of 2 shares — an estimated $116 sold.

Claris Advisors first reported a position in ASTH in Q3 2024 and held it in 1 quarter. The position peaked at $116 in Q3 2024. 179 funds tracked by Wall St. Rank hold ASTH as of Q4 2024.

Claris Advisors reported no remaining Astrana Health position as of Q4 2024 after selling out during the quarter.
Claris Advisors sold 2 Astrana Health shares in Q4 2024, an estimated $116.
Claris Advisors first reported a position in Astrana Health in Q3 2024 and held it in 1 quarter.
Claris Advisors's Astrana Health position peaked at $116 in Q3 2024.
179 funds tracked by Wall St. Rank held Astrana Health as of Q4 2024.

Based on Claris Advisors's 13F filing for Q4 2024, filed 7 Feb 2025.